NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Hydroxychloroquine with or without azithromycin for treatment of

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A

Mild or Moderate Covid-19

Summary of Guidance for Minimizing the Impact of COVID-19 on

Frontiers Therapeutic Effectiveness and Safety of Repurposing

Frontiers Drugs for the prevention and treatment of COVID-19 and

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The

Remdesivir for the treatment of hospitalized patients with severe